Heartbeam Warrant
BEATW
BEATW was delisted on the 13th of November, 2026.
8 hedge funds and large institutions have $4.22K invested in Heartbeam Warrant in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
36,600% more capital inflows, than outflows
Capital inflows: $1.1K | Capital outflows: $3
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
2.35% more ownership
Funds ownership: 20.2% → 22.55% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$746 |
| 2 |
Virtu Financial
New York
|
+$298 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$56 |
| 4 |
Clear Street
New York
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
-$3 |
BEATW Hedge Fund Activity: Q3 2026 in Review
8 of the 8,186 institutional investors tracked by Wall St. Rank reported a position in Heartbeam Warrant (BEATW) for Q3 2026, worth a combined $4.22K — down 73% from $15.6K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BEATW positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $746. The largest seller was Two Sigma Securities, cutting an estimated $3.
- 8 institutional investors held Heartbeam Warrant (BEATW) as of Q3 2026, up from 6 in Q2 2026.
- Funds reported $4.22K of Heartbeam Warrant stock for Q3 2026, down 73% quarter-over-quarter.
- 2 funds opened new Heartbeam Warrant positions in Q3 2026 and 0 closed out, a net change of +2 holders.
- The largest Heartbeam Warrant buyer in Q3 2026 was Susquehanna International Group, an estimated $746 added.
- The largest Heartbeam Warrant seller in Q3 2026 was Two Sigma Securities, an estimated $3 sold.
Based on aggregated 13F filings for Q3 2026.